№4(6) 2023

DOI 10.37219/2528-8253-2023-4-17

Falko AM, Naumenko OM

TO STUDY THE EFFECT OF N-ACETYLCYSTEINE ON THE STATE OF ANTIOXIDANT  AND REGENERATIVE ACTIVITY IN PATIENTS WITH CHRONIC RHINOSINUSITIS

Naumenko Oleksandr 
National medical University named after O.O. Bogomolets, Kyiv, Ukraine
First vice-rector, Doctor of Medical Sciences, Professor, Corresponding member of the National Academy of Science of Ukraine
E-mail: naumenko16t@ukr.net
ORCID ID: https://orcid.org/0000-0002-9001-7580
Scopus Author ID: 7005396556

Abstract

Chronic rhinosinusitis (CRS) is a heterogeneous disease characterized by localized inflammation of the upper respiratory tract. One of the methods of treatment of CRS is endonasal maxillotomy. However, the regeneration of tissues damaged during surgery remains an important issue, so the determination of markers of the inflammatory response – biochemical indicators of antioxidant and regenerative activity – is extremely important. The activity of the alteration process and the degree of postoperative damage is characterized by the concentration of glycosaminoglycans and free L-oxyproline, the state of the oxidative stress system and antioxidant defense – the content of nitrite and sulfide anion.

Aim: determination of the content of markers of antioxidant and regenerative activity in nasal mucosa ash in patients with chronic rhinosinusitis.

Materials and methods: The main group consisted of 47 patients with chronic rhinosinusitis who received standard treatment and topical N-acetylcysteine up to 10 days after surgery. The control group consisted of 49 patients who received standard treatment and 0.9% sodium chloride solution. Biochemical parameters in the nasal mucosa ash (L-oxyproline, glycosaminoglycans, nitrites and sulfide anions) were determined before treatment, on days 3, 10 and 28 after endonasal maxillotomy and for better access to the sinus for additional septoplasty. The results were statistically analyzed using Student’s t-test for two independent samples, Mann-Whitney U-test, and Wilcoxon test. Differences were considered significant at p<0.05.

Results: An increase in the concentration of nitrite on day 3 of the experiment was detected, which is a direct consequence of the high activity of iNOS during this period of the experiment. The absence of statistically significant changes in the concentration of nitrite on day 28 indicates the effective utilization of excess nitric oxide and the enhancement of antibacterial protection of the mucous membrane due to the high activity of iNOS in the long term of treatment.

There was to increase the concentration of GAG on days 3, 10 and 28 of the study in the experimental group compared to the control group and to decrease relative to the groups on the first day after surgery. The decrease in the concentration of free L-oxyproline in the experimental group on days 3, 10, 28 relatives to the first day of the postoperative period indicates the predominance of collagen breakdown over its synthesis, which prevents the development of fibrosis. The development of more intense oxidative stress was evidenced by an increased concentration of sulfide anion in patients of the control group from day 3 to day 10.

Conclusions: the use of topical N-acetylcysteine in combination with complex therapy in the postoperative period for the treatment of CRS normalizes antioxidant and regenerative activity, which in turn leads to improved tissue healing and reduced recovery time.

Key words: chronic rhinosinusitis, nasal mucosa, maxillotomy, oxidative stress, iNOS, L-oxyproline, N-acetylcysteine.

References

  1. Alanin MC, Hopkins C. Effect of functional endoscopic sinus surgery on outcomes in chronic rhinosinusitis. Curr Allergy Asthma Rep. 2020 May 27;20(7):27. doi: 10.1007/s11882-020-00932-6.
  2. Almosnino G, Little RE. Surgical management of rhinosinusitis for the allergist-immunologist. Ann Allergy Asthma Immunol. 2023 May:S1081-1206(23)00357-5. doi: 10.1016/j.anai.2023.05.015.
  3. Bhattacharyya A, Sarma P, Sharma DJ, Das KK, Kaur H, Prajapat M, et al. Rhino-orbital-cerebral-mucormycosis in COVID-19: A systematic review. Indian J Pharmacol. 2021 Jul-Aug;53(4): 317-327. doi: 10.4103/ijp.ijp_419_21.
  4. Cinar R, Iyer MR, Kunos G. Dual inhibition of CB1 receptors and iNOS, as a potential novel approach to the pharmacological management of acute and long COVID-19. Br J Pharmacol. 2022 May;179(10):2121-2127. doi: 10.1111/bph.15461.
  5. Ciprandi G, Passali D, Bellussi LM, Passali FM. Rhinosinusitis: clinical-based phenotyping. Acta Biomed. 2022 Oct;93(5):e2022211. doi: 10. 23750/abm.v93i5.12633.
  6. de Loos DD, Lourijsen ES, Wildeman MAM, Freling NJM, Wolvers MDJ, Reitsma S, et al. Prevalence of chronic rhinosinusitis in the general population based on sinus radiology and symptomatology. J Allergy Clin Immunol. 2019 Mar;143 (3):1207-1214. doi: 10.1016/j.jaci.2018.12.986.
  7. Fokkens WJ, Lund VJ, Hopkins C, Hellings PW, Kern R, Reitsma S, et al. European Position Paper on Rhinosinusitis and Nasal Polyps 2020. Rhinology. 2020 Feb;58(Suppl S29):1-464. doi: 10.4193/ 600.
  8. Fujiwara Y, Murofushi T, Koshi R, Mikami Y, Tsuda H. Reactive oxygen species-dependent release of damage-associated molecular patterns from human gingival epithelial Ca9-22 cells during butyrate or propionate exposure. J Oral Sci. 2021 Mar;63(2):195-197. doi: 10.2334/josnusd.20-0411.
  9. Kim SD, Cho KS. Treatment Strategy of Uncontrolled Chronic Rhinosinusitis with Nasal Polyps: A Review of Recent Evidence. Int J Mol Sci. 2023 Mar;24(5):5015. doi: 10.3390/ijms24055015.
  10. Licari A, Castagnoli R, De Filippo M, Foiadelli T, Tosca MA, Marseglia GL, et al. Current and emerging biologic therapies for allergic rhinitis and chronic rhinosinusitis. Expert Opin Biol Ther. 2020 Jun;20(6):609-619. doi: 10.1080/14712598. 1729350.
  11. Marin C, Hummel T, Liu Z, Mullol J. Chronic Rhinosinusitis and COVID-19. J Allergy Clin Immunol Pract. 2022 Jun;10(6):1423-1432. doi: 10.1016/j.jaip.2022.03.003.
  12. Mihalj H, Butković J, Tokić S, Štefanić M, Kizivat T, Bujak M, et al. Expression of oxidative stress and inflammation-related genes in nasal mucosa and nasal polyps from patients with chronic rhinosinusitis. Int J Mol Sci. 2022 May 15;23(10): doi: 10.3390/ijms23105521.
  13. Oronsky B, Larson C, Hammond TC, Oronsky A, Kesari S, Lybeck M, et al. A Review of Persistent Post-COVID Syndrome (PPCS). Clin Rev Allergy Immunol. 2023 Feb;64(1):66-74. doi: 10.1007/ s12016-021-08848-3.
  14. Passali GC, Passali D, Cingi C, Ciprandi G. Smell impairment in patients with chronic rhinosinusitis: a real-life study. Eur Arch Otorhinolaryngol. 2022 Feb;279(2):773-777. doi: 10.1007/s00405-021-06848-9.
  15. Pedre B, Barayeu U, Ezeriņa D, Dick TP. The mechanism of action of N-acetylcysteine (NAC): The emerging role of H2S and sulfane sulfur species. Pharmacol Ther. 2021 Dec;228:107916. doi: 10.1016/j.pharmthera.2021.107916.
  16. Smith TL, Schlosser RJ, Mace JC, Alt JA, Beswick DM, DeConde AS, et al. Long-term outcomes of endoscopic sinus surgery in the management of adult chronic rhinosinusitis. Int Forum Allergy Rhinol. 2019;9(8):831-41. doi: 10.1002/ alr.22369.
  17. Xu X, Reitsma S, Wang Y, Fokkens WJ. Highlights in the advances of chronic rhinosinusitis. Allergy. 2021 Nov;76(11):3349-3358. doi: 10.1111/all.14892.
  18. Yazaki K, Matsuno Y, Yoshida K, Sherpa M, Nakajima M, Matsuyama M, et al. ROS-Nrf2 pathway mediates the development of TGF-β1-induced epithelial-mesenchymal transition through the activation of Notch signaling. Eur J Cell Biol. 2021 Sep-Nov;100(7-8):151181. doi: 10.1016/ ejcb.2021.151181.
  19. Zuhra K, Tomé CS, Masi L, Giardina G, Paulini G, Malagrinò F, et al. N-Acetylcysteine Serves as Substrate of 3-Mercaptopyruvate Sulfurtransferase and Stimulates Sulfide Metabolism in Colon Cancer Cells. Cells. 2019 Aug 4;8(8):828. doi: 10.3390/cells8080828.